Lewy body dementia
Lewy body dementia
Explore linked clinical trials. Standard reference: MONDO:000748889 results ยท Page 1 of 4
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Rhythmic Entrainment and Alertness in Lewy Body Dementia | Lewy body dementia, basal ganglia disorder, brain disorder, central nervous system disorder, cognitive disorder, dementia, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, psychiatric disorder, synucleinopathy | Not yet recruiting | Not applicable | 2026-10-09 | NCT07846189 | |
| A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7) | Alzheimer disease, Cognition Disorders, Cognitive Dysfunction, Lewy body dementia, Nutritional and Metabolic Diseases, amyloidosis, basal ganglia disorder, brain disorder, central nervous system disorder, cognitive disorder, dementia, metabolic disease, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, proteostasis deficiencies, psychiatric disorder, synucleinopathy, tauopathy | Recruiting | Phase 2 | 2026-10-08 | NCT07589595 | |
| Single-center Study of Gustation in Idiopathic Parkinson's Disease and Lewy Body Disease Using Gustatory Evoked Potential Analysis | Lewy body dementia, Parkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, cognitive disorder, dementia, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, psychiatric disorder, synucleinopathy | Recruiting | Not applicable | 2026-10-07 | NCT06439355 | |
| Non-invasive Neurostimulation as a Tool for Diagnostics and Management for Neurodegenerative Diseases | Alzheimer disease, Frontotemporal Lobar Degeneration, Lewy body dementia, Nutritional and Metabolic Diseases, TDP-43 proteinopathy, basal ganglia disorder, brain disorder, central nervous system disorder, cognitive disorder, dementia, frontotemporal dementia, metabolic disease, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, proteostasis deficiencies, psychiatric disorder, synucleinopathy, tauopathy | Recruiting | Not applicable | 2026-10-02 | NCT05326750 | |
| Visual Hallucinations in Lewy Body Diseases | Hallucinations, Hallucinations, Visual, Lewy body dementia, Neurobehavioral Manifestations, Neurologic Manifestations, Parkinson disease, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, basal ganglia disorder, brain disorder, central nervous system disorder, cognitive disorder, dementia, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, perceptual disorders, psychiatric disorder, synucleinopathy | Recruiting | Not stated | 2026-09-30 | NCT07849413 | |
| Transcranial Alternating Current Stimulation in Lewy Body Dementia | Lewy body dementia, basal ganglia disorder, brain disorder, central nervous system disorder, cognitive disorder, dementia, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, psychiatric disorder, synucleinopathy | Recruiting | Not applicable | 2026-09-22 | NCT07375771 | |
| Promoting Goals-of-Care Discussions for Patients With Memory Problems and Their Caregivers | Alzheimer disease, Arterial Occlusive Diseases, Chronic Disease, Cognition Disorders, Cognitive Dysfunction, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Creutzfeldt Jacob disease, Disease Attributes, Dyskinesias, Frontotemporal Lobar Degeneration, Huntington disease, Infections, Leukoencephalopathies, Lewy body dementia, Mixed Dementias, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, TDP-43 proteinopathy, arteriosclerosis disorder, basal ganglia disorder, brain disorder, cardiovascular disorder, central nervous system disorder, central nervous system infectious disorder, cerebrovascular disorder, choreatic disease, cognitive disorder, dementia, hereditary disease, inherited neurodegenerative disorder, intracranial arterial disease, intracranial arteriosclerosis, metabolic disease, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, prion disease, proteostasis deficiencies, psychiatric disorder, synucleinopathy, tauopathy, vascular dementia, vascular disorder | Active, not recruiting | Not applicable | 2026-09-21 | NCT05596760 | |
| Pulsed Electromagnetic Field Treatment With Dementia Patients | Alzheimer disease, Arterial Occlusive Diseases, Leukoencephalopathies, Lewy body dementia, arteriosclerosis disorder, basal ganglia disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, cognitive disorder, dementia, intracranial arterial disease, intracranial arteriosclerosis, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, psychiatric disorder, synucleinopathy, tauopathy, vascular dementia, vascular disorder | Recruiting | Not applicable | 2026-09-17 | NCT06862557 | |
| Multi-Center Study of Natural History in Atypical Parkinsonian Syndromes (MAPS-NH) | Lewy body dementia, Neurologic Manifestations, Ocular Motility Disorders, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, autonomic nervous system disorder, basal ganglia disorder, brain disorder, central nervous system disorder, cognitive disorder, corticobasal degeneration disorder, cranial nerve neuropathy, dementia, eye disorder, movement disorder, multiple system atrophy, nervous system disorder, neurodegenerative disease, ophthalmoplegia, palsy, parkinsonian disorder, primary dysautonomia, psychiatric disorder, synucleinopathy, tauopathy | Recruiting | Not stated | 2026-09-08 | NCT07805967 | |
| Speech-Based Artificial Intelligence for Detection of Dementia in Danish Patients (DetectAI) | Alzheimer disease, Arterial Occlusive Diseases, Cognition Disorders, Cognitive Dysfunction, Frontotemporal Lobar Degeneration, Leukoencephalopathies, Lewy body dementia, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, TDP-43 proteinopathy, arteriosclerosis disorder, basal ganglia disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, cognitive disorder, dementia, disease, frontotemporal dementia, intracranial arterial disease, intracranial arteriosclerosis, metabolic disease, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, proteostasis deficiencies, psychiatric disorder, synucleinopathy, tauopathy, vascular dementia, vascular disorder | Not yet recruiting | Not stated | 2026-09-02 | NCT07200739 | |
| Neurodegenerative Diseases Progression Markers (MARKERS-NDD) | Alzheimer disease, Cognition Disorders, Cognitive Dysfunction, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Frontotemporal Lobar Degeneration, Lewy body dementia, Neurologic Manifestations, Nutritional and Metabolic Diseases, Ocular Motility Disorders, Parkinson disease, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, TDP-43 proteinopathy, amyotrophic lateral sclerosis, autonomic nervous system disorder, basal ganglia disorder, brain disorder, central nervous system disorder, cognitive disorder, corticobasal degeneration disorder, cranial nerve neuropathy, dementia, eye disorder, hereditary disease, inherited neurodegenerative disorder, iron metabolism disease, iron poisoning, metabolic disease, motor neuron disorder, movement disorder, multiple system atrophy, nervous system disorder, neuroaxonal dystrophy, neurodegeneration with brain iron accumulation, neurodegenerative disease, neuromuscular disease, ophthalmoplegia, palsy, pantothenate kinase-associated neurodegeneration, parkinsonian disorder, primary dysautonomia, proteostasis deficiencies, psychiatric disorder, spinal cord disorder, synucleinopathy, tauopathy | Recruiting | Not stated | 2026-09-02 | NCT06596746 | |
| Biofluid Research on Age-Related or Inherited Neurodegeneration | Alzheimer disease, Lewy body dementia, Nerve Degeneration, Neurobehavioral Manifestations, Neurologic Manifestations, Nutritional and Metabolic Diseases, Ocular Motility Disorders, Parkinson disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, TDP-43 proteinopathy, amyotrophic lateral sclerosis, aphasia, basal ganglia disorder, brain disorder, central nervous system disorder, cognitive disorder, communication disorder, cranial nerve neuropathy, dementia, eye disorder, language disorder, limbic-predominant age-related TDP-43 encephalopathy, metabolic disease, motor neuron disorder, movement disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, ophthalmoplegia, palsy, parkinsonian disorder, primary progressive aphasia, proteostasis deficiencies, psychiatric disorder, speech disorder, spinal cord disorder, synucleinopathy, tauopathy | Recruiting | Not stated | 2026-09-01 | NCT07798700 | |
| Exploring the Olfactory Mucosa, Blood and Urine for the Identification of Early Biomarkers of Parkinson's Disease, Atypical Parkinsonisms and Neurocognitive Disorders Due to Lewy Body Disease | Lewy body dementia, Parkinson disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, autonomic nervous system disorder, basal ganglia disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cognitive disorder, dementia, disease, familial cylindromatosis, hypotensive disorder, movement disorder, multiple system atrophy, nervous system disorder, neurodegenerative disease, parkinsonian disorder, primary dysautonomia, psychiatric disorder, synucleinopathy, vascular disorder | Active, not recruiting | Not stated | 2026-08-28 | NCT06846658 | |
| Telehealth in Lewy Body Dementia | Lewy body dementia, Parkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, cognitive disorder, dementia, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, psychiatric disorder, synucleinopathy | Active, not recruiting | Not applicable | 2026-08-20 | NCT05014971 | |
| ENhancing Outcomes in Cognitive Impairment Through Use of Home Sleep ApNea Testing | Alzheimer disease, Apnea, Arterial Occlusive Diseases, Cognition Disorders, Cognitive Dysfunction, Dyssomnias, Leukoencephalopathies, Lewy body dementia, Mild Cognitive Impairment, Mixed Dementias, Respiration Disorders, Sleep Disorders, Intrinsic, arteriosclerosis disorder, basal ganglia disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, cognitive disorder, dementia, intracranial arterial disease, intracranial arteriosclerosis, movement disorder, nervous system disorder, neurodegenerative disease, obstructive sleep apnea syndrome, parkinsonian disorder, psychiatric disorder, respiratory system disorder, sleep apnea syndrome, sleep-wake disorder, synucleinopathy, tauopathy, vascular dementia, vascular disorder | Recruiting | Not applicable | 2026-08-20 | NCT04335994 | |
| 5-HT RBD REM Sleep Behavior Disorder | Lewy body dementia, Parasomnias, Parkinson disease, REM Sleep Parasomnias, REM sleep behavior disorder, basal ganglia disorder, brain disorder, central nervous system disorder, cognitive disorder, dementia, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, psychiatric disorder, sleep-wake disorder, synucleinopathy | Active, not recruiting | Not applicable | 2026-08-10 | NCT06467461 | |
| Sociodemographic Factors and Criminal Behaviour Preceding Neurodegenerative Disease - Retrospective Register Study | Alzheimer disease, Arterial Occlusive Diseases, Cognition Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyskinesias, Frontotemporal Lobar Degeneration, Huntington disease, Leukoencephalopathies, Lewy body dementia, Neurologic Manifestations, Nutritional and Metabolic Diseases, Ocular Motility Disorders, Parkinson disease, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, TDP-43 proteinopathy, amyotrophic lateral sclerosis, arteriosclerosis disorder, autonomic nervous system disorder, basal ganglia disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, choreatic disease, cognitive disorder, corticobasal degeneration disorder, cranial nerve neuropathy, dementia, eye disorder, frontotemporal dementia, hereditary disease, inherited neurodegenerative disorder, intracranial arterial disease, intracranial arteriosclerosis, metabolic disease, motor neuron disorder, movement disorder, multiple system atrophy, nervous system disorder, neurodegenerative disease, neuromuscular disease, ophthalmoplegia, palsy, parkinsonian disorder, primary dysautonomia, progressive supranuclear palsy, proteostasis deficiencies, psychiatric disorder, spinal cord disorder, synucleinopathy, tauopathy, vascular dementia, vascular disorder | Active, not recruiting | Not stated | 2026-08-10 | NCT06209515 | |
| MIBG in Aging and Neurologic Disorders | Cognition Disorders, Cognitive Dysfunction, Lewy body dementia, Mild Cognitive Impairment, Parasomnias, REM Sleep Parasomnias, REM sleep behavior disorder, basal ganglia disorder, brain disorder, central nervous system disorder, cognitive disorder, dementia, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, psychiatric disorder, sleep-wake disorder, synucleinopathy | Enrolling by invitation | Phase 4 | 2026-07-30 | NCT05514106 | |
| Digital Health Technologies for Progressive Supranuclear Palsy and Dementia With Lewy Bodies | Lewy body dementia, Neurologic Manifestations, Ocular Motility Disorders, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, basal ganglia disorder, brain disorder, central nervous system disorder, cognitive disorder, cranial nerve neuropathy, dementia, eye disorder, movement disorder, nervous system disorder, neurodegenerative disease, ophthalmoplegia, palsy, parkinsonian disorder, psychiatric disorder, supranuclear palsy, progressive, 1, synucleinopathy, tauopathy | Not yet recruiting | Not stated | 2026-07-01 | NCT07240805 | |
| 18F-mFBG Cardiac Uptake With Lewy Body Dementia | Lewy body dementia, Parkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, cognitive disorder, dementia, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, psychiatric disorder, synucleinopathy | Recruiting | Phase 2 | 2026-07-01 | NCT07176286 | |
| Neurologic Stem Cell Treatment Study | Alzheimer disease, Brain Damage, Chronic, Brain Injuries, Traumatic, CNS demyelinating autoimmune disease, Cerebral Small Vessel Diseases, Chronic Disease, Cognition Disorders, Cognitive Dysfunction, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Craniocerebral Trauma, Diabetes Complications, Disease Attributes, Frontotemporal Lobar Degeneration, Hemorrhage, Infarction, Intracranial Hemorrhages, Lewy Body Variant of Alzheimer Disease, Lewy body dementia, Necrosis, Nerve Degeneration, Neurologic Manifestations, Nutritional and Metabolic Diseases, Ocular Motility Disorders, Parkinson disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, TDP-43 proteinopathy, amyotrophic lateral sclerosis, autoimmune disease, autoimmune disorder of the nervous system, autonomic nervous system disorder, basal ganglia disorder, brain disorder, brain infarction, brain injury, brain ischemia, cardiovascular disorder, central nervous system disorder, cerebral arterial disease, cerebral infarction, cerebrovascular disorder, cognitive disorder, cranial nerve neuropathy, dementia, dementia pugilistica, demyelinating disease, diabetes mellitus, diabetic neuropathy, endocrine system disorder, eye disorder, frontotemporal dementia, hereditary disease, hypotensive disorder, immune system disorder, injury, intracerebral hemorrhage, intracranial arterial disease, ischemic disease, metabolic disease, motor neuron disorder, movement disorder, multiple sclerosis, multiple system atrophy, nervous system disorder, nervous system injury, neurodegenerative disease, neuromuscular disease, ophthalmoplegia, palsy, parkinsonian disorder, peripheral nervous system disorder, peripheral neuropathy, primary dysautonomia, progressive supranuclear palsy, proteostasis deficiencies, psychiatric disorder, spinal cord disorder, stroke disorder, synucleinopathy, tauopathy, vascular dementia, vascular disorder | Recruiting | Not applicable | 2026-06-26 | NCT02795052 | |
| Evaluating How Red-light Therapy Applied to the Head Affects Symptoms, Daily Life, and Brain Activity in People With Dementia With Lewy Bodies | Lewy body dementia, basal ganglia disorder, brain disorder, central nervous system disorder, cognitive disorder, dementia, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, psychiatric disorder, synucleinopathy | Not yet recruiting | Not applicable | 2026-06-23 | NCT07602296 | |
| Imaging of Brain Amyloid Plaques in the Aging Population | Alzheimer disease, Arterial Occlusive Diseases, Frontotemporal Lobar Degeneration, Leukoencephalopathies, Lewy body dementia, Nutritional and Metabolic Diseases, TDP-43 proteinopathy, arteriosclerosis disorder, basal ganglia disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, cognitive disorder, dementia, frontotemporal dementia, intracranial arterial disease, intracranial arteriosclerosis, metabolic disease, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, proteostasis deficiencies, psychiatric disorder, synucleinopathy, tauopathy, vascular dementia, vascular disorder | Enrolling by invitation | Phase 4 | 2026-06-23 | NCT00950430 | |
| Alpha-synuclein Education and Disclosure in Individuals With Preclinical and Symptomatic Lewy Body Disease | Lewy body dementia, basal ganglia disorder, brain disorder, central nervous system disorder, cognitive disorder, dementia, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, psychiatric disorder, synucleinopathy | Not yet recruiting | Not stated | 2026-06-15 | NCT07646652 | |
| Natural History Study of Synucleinopathies | Lewy body dementia, Parasomnias, Parkinson disease, REM Sleep Parasomnias, REM sleep behavior disorder, autonomic nervous system disorder, basal ganglia disorder, brain disorder, central nervous system disorder, cognitive disorder, dementia, movement disorder, multiple system atrophy, nervous system disorder, neurodegenerative disease, parkinsonian disorder, primary dysautonomia, psychiatric disorder, pure autonomic failure, sleep-wake disorder, synucleinopathy | Recruiting | Not stated | 2026-06-10 | NCT01799915 |